🎯 check CAL-101 (Idelalisib) product page
CAL-101 (Idelalisib) is a potent, selective PI3Kδ inhibitor. It affects the PI3K/AKT/mTOR signaling pathway by binding to the kinase ATP-binding cleft and reducing AKT phosphorylation, effectively inhibiting tumor cell proliferation and promoting apoptosis in hematological malignancies.